the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients | stella

Learn Data For Researchers Find trials matched to me

Learn Data For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

the Clinical Outcome of Empagliflozin in Pediatric Heart Failure Patients | stella

Back to Heart Failure trials

Recruiting

Plain-English translation of NCT07692256 on ClinicalTrials.gov ↗ · Source last updated July 2026 · How we translate trials

Read our Heart Failure research guide →

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(1 site)

Egypt

Ain Shams Hospital, Cairo, Cairo Governorate

Key details

Phase

Testing effectiveness

Sponsor

Ain Shams University

Enrollment target

~60 participants

Started

December 2025

Primary completion

December 2026

Age range

1 Month – 18 Years

Last updated on clinicaltrials.gov in July 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

nassar elsayed nassar, master candidate

Ain Shams University

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.